ED-Finanzas

No es posible guardar favoritos sin iniciar sesión.

Usá Login / Registrar en el header (usuario + contraseña).

OABI

OmniAb Inc · NASD

Healthcare · Biotechnology · USA · Small

3.82
+0.44 (+13.02%)
Aug 17 3:59 PM ET

OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Chart

Lightweight Charts · Yahoo Finance

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GUSTAFSON KURT A Officer Apr 07 '26 Proposed Sale 1.49 6,913 10,266 Apr 07 08:33 PM
FOEHR MATTHEW W President and CEO Apr 07 '26 Option Exercise 0.00 36,459 0 4,439,736 Apr 07 08:26 PM
FOEHR MATTHEW W President and CEO Apr 07 '26 Sale 1.49 19,244 28,674 4,420,492 Apr 07 08:26 PM
FOEHR MATTHEW W Officer Apr 07 '26 Proposed Sale 1.49 19,244 28,577 Apr 07 08:25 PM
GUSTAFSON KURT A Executive VP, Finance and CFO Apr 07 '26 Option Exercise 0.00 13,542 0 268,396 Apr 07 08:25 PM
GUSTAFSON KURT A Executive VP, Finance and CFO Apr 07 '26 Sale 1.49 6,913 10,300 261,483 Apr 07 08:25 PM
Berkman Charles S Chief Legal Officer Apr 07 '26 Option Exercise 0.00 13,542 0 406,242 Apr 07 08:23 PM
Berkman Charles S Chief Legal Officer Apr 07 '26 Sale 1.49 7,157 10,664 399,085 Apr 07 08:23 PM
Berkman Charles S Officer Apr 07 '26 Proposed Sale 1.49 7,157 10,628 Apr 07 08:12 PM
Berkman Charles S Chief Legal Officer Feb 18 '26 Option Exercise 0.00 18,750 0 402,373 Feb 18 06:36 PM
Berkman Charles S Chief Legal Officer Feb 18 '26 Sale 1.71 9,673 16,541 392,700 Feb 18 06:36 PM
GUSTAFSON KURT A Executive VP, Finance and CFO Feb 18 '26 Option Exercise 0.00 18,750 0 278,152 Feb 18 06:35 PM
GUSTAFSON KURT A Executive VP, Finance and CFO Feb 18 '26 Sale 1.71 9,301 15,905 268,851 Feb 18 06:35 PM
FOEHR MATTHEW W President and CEO Feb 18 '26 Sale 1.71 30,843 52,742 4,403,277 Feb 18 06:34 PM
FOEHR MATTHEW W President and CEO Feb 16 '26 Option Exercise 0.00 36,458 0 4,396,541 Feb 17 06:22 PM
FOEHR MATTHEW W President and CEO Feb 17 '26 Sale 1.70 20,754 35,282 4,375,787 Feb 17 06:22 PM
GUSTAFSON KURT A Executive VP, Finance and CFO Feb 16 '26 Option Exercise 0.00 13,542 0 266,230 Feb 17 06:20 PM
GUSTAFSON KURT A Executive VP, Finance and CFO Feb 17 '26 Sale 1.70 6,828 11,608 259,402 Feb 17 06:20 PM
Berkman Charles S Chief Legal Officer Feb 16 '26 Option Exercise 0.00 13,542 0 390,613 Feb 17 06:18 PM
Berkman Charles S Chief Legal Officer Feb 17 '26 Sale 1.70 6,990 11,883 383,623 Feb 17 06:18 PM
FOEHR MATTHEW W Officer Feb 17 '26 Proposed Sale 1.70 20,483 34,821 Feb 17 04:33 PM
Berkman Charles S Officer Feb 17 '26 Proposed Sale 1.70 6,891 11,715 Feb 17 04:29 PM
GUSTAFSON KURT A Officer Feb 17 '26 Proposed Sale 1.70 6,891 11,715 Feb 17 04:27 PM
Berkman Charles S Chief Legal Officer Dec 07 '25 Option Exercise 0.00 15,621 0 385,115 Dec 09 09:02 AM
Berkman Charles S Chief Legal Officer Dec 08 '25 Sale 1.96 8,044 15,766 377,071 Dec 09 09:02 AM
GUSTAFSON KURT A Executive VP, Finance and CFO Dec 07 '25 Option Exercise 0.00 46,500 0 276,610 Dec 09 09:02 AM
GUSTAFSON KURT A Executive VP, Finance and CFO Dec 08 '25 Sale 1.96 23,922 46,887 252,688 Dec 09 09:02 AM
FOEHR MATTHEW W President and CEO Dec 07 '25 Option Exercise 0.00 26,554 0 4,373,749 Dec 09 09:01 AM
FOEHR MATTHEW W President and CEO Dec 08 '25 Sale 1.96 13,666 26,785 4,360,083 Dec 09 09:01 AM
GUSTAFSON KURT A Officer Dec 08 '25 Proposed Sale 1.96 23,922 46,910 Dec 08 07:17 PM
FOEHR MATTHEW W Officer Dec 08 '25 Proposed Sale 1.96 13,666 26,798 Dec 08 07:15 PM
Berkman Charles S Officer Dec 08 '25 Proposed Sale 1.96 8,044 15,774 Dec 08 07:14 PM
HIGGINS JOHN L Director Nov 07 '25 Buy 1.38 41,038 56,632 2,929,148 Nov 10 08:30 AM
HIGGINS JOHN L Director Nov 06 '25 Buy 1.41 36,223 51,074 2,888,110 Nov 10 08:30 AM